September 2022
203 articles-
Sep 30 · 08:08Biotechnology Daily
Iveric hits again in pivotal eye disease program, keeping it on Apellis' tail in race to market
-
Sep 30 · 08:07Biotechnology Daily
Precision rejigs leadership team, tasking CSO with managing partnerships in wake of Novartis pact
-
Sep 30 · 08:06Biotechnology Daily
Mayo Clinic AI could predict labor outcomes in real time: study
-
Sep 30 · 08:05Biotechnology Daily
Hormone that could improve cognitive function in Down syndrome identified
-
Sep 30 · 08:03Bio Business News
Philips settles with DOJ for $29M in 2 alleged False Claims Act violations
-
Sep 30 · 08:02Bio Business News
BMS-backed Arsenal Bio pulls trigger on $220M series B, touting potential fleet of gene-edited cell therapies
-
Sep 30 · 08:01Bio Business News
Facing €200M phase 3 bill, Abivax sells stock at knockdown price to keep lights on into next year
-
Sep 30 · 08:00Bio Business News
Targeting Novo Nordisk in China's obesity market with a unique proposition, LeaderMed eyes US IPO
-
Sep 30 · 05:48Market Watch
Eurozone Inflation posts new record high of 10.0% in September
-
Sep 29 · 10:10Biotechnology Daily
Beyond headlines and amyloid, the Alzheimer's pipeline chugs along
-
Sep 29 · 10:06Biotechnology Daily
Medtronic's new MiniMed insulin pump adds 27% boost to time in range, study finds
-
Sep 29 · 10:05Biotechnology Daily
Vibrant Gastro passes vibrating constipation pill through FDA review
-
Sep 29 · 10:03Bio Business News
Uncovering a link between lung cancer and chronic pain—and a druggable pathway for both
-
Sep 29 · 10:02Bio Business News
Novo Nordisk ponies up $1.1B for Forma in effort to shape up sickle cell disease market
-
Sep 29 · 10:01Bio Business News
As EU challenge intensifies, Illumina clocks a stateside win in FTC antitrust case over Grail buy
-
Sep 29 · 09:59Bio Business News
Finch axes more than a 3rd of its workforce days after Takeda clips its fiscal wings
-
Sep 29 · 09:58Bio Business News
Novartis R&D chief Jay Bradner bids adieu to the Swiss Big Pharma
-
Sep 28 · 10:26Biotechnology Daily
AnaptysBio's HARP plays dud note, prompting rethink of imsidolimab strategy
-
Sep 28 · 10:25Biotechnology Daily
As activist investor ratchets up pressure, Mereo makes more cuts to extend cash runway into 2025
-
Sep 28 · 10:24Biotechnology Daily
Medtronic picks up BioIntelliSense's round-the-clock vital sign monitor in distribution deal
-
Sep 28 · 10:22Biotechnology Daily
One protein, many cancers: Immatics finds a multi-tumor target for adoptive T-cell therapies
-
Sep 28 · 10:21Bio Business News
JenaValve nabs $100M to clear a path toward FDA approval of dual-use TAVR system
-
Sep 28 · 10:20Bio Business News
Guardant, Merck KGaA expand precision therapeutics collab, focusing on hard-to-treat cancer
-
Sep 28 · 10:18Bio Business News
Guess what's SPAC? Ocean Biomedical resuscitates Wall Street play all but dead in 2022